4,5,6,7-tetrahydro-1-benzothiophene-3-carbaldehyde, 95.0%, 1g

Cholesterol Hydrogen Succinate>97.0%(T)10g

(2E)-1-(4-bromophenyl)-3-(3-methylthiophen-2-yl)prop-2-en-1-one, 95.0%, 2g

2,2-Dimethyltetrahydro-2H-pyran-4-carboxylic acid, 95.0%, 500mg

5''-(3',5'-dicarboxy-[1,1'-biphenyl]-4-yl)-[1,1':4',1'':3'',1''':4''',1''''-quinquephenyl]-3,3'''',5,5''''-tetracarboxylic acid, 97%, 1g

2-[4-(4-Fluoro-benzyloxy)-phenyl]-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane, 98%, 5g

ETHYL 5-AMINO-4,6-DIHYDROXYNICOTINATE, 95.0%, 1g

Asta di dispersione ULTRA-TURRAX® per dispositivo di dispersione T 18 digitale 18 N - 19 G, da 10 a 1500 ml, 1 pezzo

(R)-1-(2,5-Dichlorophenyl)ethan-1-amine, 95%, 100mg

5-Methyl-1H-indazole, 95.0%, 10g

3-(3-Fluoro-4-isopropoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine, 95%, 5g

2-Bromo-1,7-naphthyridine, 95.0%, 1g

Methyl 4-oxopiperidine-1-carboxylate, 95.0%, 250mg